Buy Millendo Therapeutics Inc Stock | MLND Stock Price & Latest News | Public
MLND

Millendo Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap

    About MLND

    Millendo Therapeutics, Inc. engages in the development of treatments for orphan endocrine diseases. Its product pipeline includes Livoletide (AZP-531) for the treatment of Prader-Willi syndrome; Nevanimibe for classic congenital adrenal hyperplasia; and Neurokinin 3 rec...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.29
    -0.58
    -0.87
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.46

    Actual EPS
    Q3 2020

    Stats

    Market Cap$29,44M
    Volume5,64k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.88
    1 Year Low$1.26
    Open$1.56
    High$1.56
    Low$1.50

    Buy any stock with any amount of money.

    Download the App
    Download the app